TRIN

TRIN
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $66.229M ▼ | $16.959M ▲ | $27.645M ▼ | 41.742% ▼ | $0.52 ▼ | $28.289M ▼ |
| Q2-2025 | $76.093M ▲ | $16.014M ▲ | $41.414M ▲ | 54.426% ▲ | $0.63 ▲ | $42.035M ▲ |
| Q1-2025 | $60.089M ▼ | $14.73M ▼ | $27.087M ▼ | 45.078% ▼ | $0.43 ▼ | $27.703M ▼ |
| Q4-2024 | $82.106M ▲ | $16.415M ▲ | $45.858M ▲ | 55.852% ▲ | $0.77 ▲ | $46.639M ▲ |
| Q3-2024 | $56.806M | $14.919M | $24.4M | 42.953% | $0.47 | $25.019M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $9.467M ▼ | $2.247B ▲ | $1.249B ▲ | $998.264M ▲ |
| Q2-2025 | $26.251M ▲ | $2.045B ▲ | $1.121B ▲ | $923.568M ▲ |
| Q1-2025 | $8.386M ▼ | $1.857B ▲ | $1.024B ▲ | $833.395M ▲ |
| Q4-2024 | $9.627M ▲ | $1.774B ▲ | $951.259M ▼ | $822.982M ▲ |
| Q3-2024 | $8.535M | $1.735B | $977.968M | $756.795M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $27.645M ▼ | $27.202M ▼ | $-210.896M ▼ | $166.91M ▲ | $-16.784M ▼ | $27.131M ▼ |
| Q2-2025 | $41.414M ▲ | $42.82M ▲ | $-166.532M ▼ | $141.577M ▲ | $17.865M ▲ | $42.64M ▲ |
| Q1-2025 | $27.087M ▼ | $-1.97M ▼ | $-61.477M ▼ | $62.206M ▲ | $-1.241M ▼ | $-2.076M ▼ |
| Q4-2024 | $45.858M ▲ | $18.406M ▲ | $-136K ▼ | $-17.178M ▼ | $1.092M ▲ | $18.27M ▲ |
| Q3-2024 | $24.4M | $-232.023M | $-125K | $194.581M | $-37.567M | $-232.148M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Trinity Capital presents the profile of a growing, niche-focused specialty lender that has moved quickly to scale its balance sheet and diversify its lending verticals. The income statement shows that the model can be quite profitable but also volatile, reflecting exposure to high‑growth, venture‑backed borrowers and to changing market conditions. The balance sheet and cash‑flow patterns are consistent with a leveraged finance company that is actively expanding its loan book and relies on external capital to do so. Competitive strengths include deep venture relationships, specialized underwriting, tailored products, and an internally managed structure that aligns incentives. At the same time, rising leverage, dependence on capital markets, and concentration in riskier borrower segments introduce meaningful cyclical and credit risks. Overall, the story is one of a differentiated platform with clear advantages in its niche, balanced by the need to carefully manage credit quality, funding, and execution as it continues to grow and broaden its strategy.
NEWS
November 13, 2025 · 8:25 AM UTC
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Read more
November 5, 2025 · 8:05 AM UTC
Trinity Capital Inc. Reports Third Quarter 2025 Financial Results
Read more
October 23, 2025 · 8:00 AM UTC
Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry
Read more
October 21, 2025 · 8:00 AM UTC
Trinity Capital Inc. Provides $15 Million in Growth Capital to Kard, Accelerating Growth of Its Commerce Media Network
Read more
October 14, 2025 · 8:10 AM UTC
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
Read more
About Trinity Capital Inc.
https://www.trincapinvestment.comTrinity Capital Inc. is a business development company. It is a venture capital firm specializing in venture debt to growth stage companies looking for loans and/or equipment financing. Trinity Capital Inc. was founded in 2019 is based in Phoenix, Arizona with additional offices in Lutherville-Timonium, Maryland, San Diego, California and Austin, Texas.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $66.229M ▼ | $16.959M ▲ | $27.645M ▼ | 41.742% ▼ | $0.52 ▼ | $28.289M ▼ |
| Q2-2025 | $76.093M ▲ | $16.014M ▲ | $41.414M ▲ | 54.426% ▲ | $0.63 ▲ | $42.035M ▲ |
| Q1-2025 | $60.089M ▼ | $14.73M ▼ | $27.087M ▼ | 45.078% ▼ | $0.43 ▼ | $27.703M ▼ |
| Q4-2024 | $82.106M ▲ | $16.415M ▲ | $45.858M ▲ | 55.852% ▲ | $0.77 ▲ | $46.639M ▲ |
| Q3-2024 | $56.806M | $14.919M | $24.4M | 42.953% | $0.47 | $25.019M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $9.467M ▼ | $2.247B ▲ | $1.249B ▲ | $998.264M ▲ |
| Q2-2025 | $26.251M ▲ | $2.045B ▲ | $1.121B ▲ | $923.568M ▲ |
| Q1-2025 | $8.386M ▼ | $1.857B ▲ | $1.024B ▲ | $833.395M ▲ |
| Q4-2024 | $9.627M ▲ | $1.774B ▲ | $951.259M ▼ | $822.982M ▲ |
| Q3-2024 | $8.535M | $1.735B | $977.968M | $756.795M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $27.645M ▼ | $27.202M ▼ | $-210.896M ▼ | $166.91M ▲ | $-16.784M ▼ | $27.131M ▼ |
| Q2-2025 | $41.414M ▲ | $42.82M ▲ | $-166.532M ▼ | $141.577M ▲ | $17.865M ▲ | $42.64M ▲ |
| Q1-2025 | $27.087M ▼ | $-1.97M ▼ | $-61.477M ▼ | $62.206M ▲ | $-1.241M ▼ | $-2.076M ▼ |
| Q4-2024 | $45.858M ▲ | $18.406M ▲ | $-136K ▼ | $-17.178M ▼ | $1.092M ▲ | $18.27M ▲ |
| Q3-2024 | $24.4M | $-232.023M | $-125K | $194.581M | $-37.567M | $-232.148M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Trinity Capital presents the profile of a growing, niche-focused specialty lender that has moved quickly to scale its balance sheet and diversify its lending verticals. The income statement shows that the model can be quite profitable but also volatile, reflecting exposure to high‑growth, venture‑backed borrowers and to changing market conditions. The balance sheet and cash‑flow patterns are consistent with a leveraged finance company that is actively expanding its loan book and relies on external capital to do so. Competitive strengths include deep venture relationships, specialized underwriting, tailored products, and an internally managed structure that aligns incentives. At the same time, rising leverage, dependence on capital markets, and concentration in riskier borrower segments introduce meaningful cyclical and credit risks. Overall, the story is one of a differentiated platform with clear advantages in its niche, balanced by the need to carefully manage credit quality, funding, and execution as it continues to grow and broaden its strategy.
NEWS
November 13, 2025 · 8:25 AM UTC
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Read more
November 5, 2025 · 8:05 AM UTC
Trinity Capital Inc. Reports Third Quarter 2025 Financial Results
Read more
October 23, 2025 · 8:00 AM UTC
Trinity Capital Inc. Provides Equipment Financing to Bobbie, Bolstering Domestic Infant Formula Industry
Read more
October 21, 2025 · 8:00 AM UTC
Trinity Capital Inc. Provides $15 Million in Growth Capital to Kard, Accelerating Growth of Its Commerce Media Network
Read more
October 14, 2025 · 8:10 AM UTC
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight Cancer
Read more

CEO
Kyle Steven Brown
Compensation Summary
(Year 2024)

CEO
Kyle Steven Brown
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.
2.791M Shares
$41.335M

VAN ECK ASSOCIATES CORP
1.746M Shares
$25.861M

MELIA WEALTH LLC
1.179M Shares
$17.465M

MARSHALL WACE, LLP
1.151M Shares
$17.05M

GREENWICH INVESTMENT MANAGEMENT, INC.
1.144M Shares
$16.943M

TWO SIGMA INVESTMENTS, LP
986.184K Shares
$14.605M

ROCKEFELLER CAPITAL MANAGEMENT L.P.
915.784K Shares
$13.563M

INVESCO LTD.
838.936K Shares
$12.425M

UBS GROUP AG
806.897K Shares
$11.95M

EMERALD ADVISERS, LLC
806.171K Shares
$11.939M

FRANKLIN RESOURCES INC
566.258K Shares
$8.386M

TWO SIGMA ADVISERS, LP
549.9K Shares
$8.144M

EMERALD MUTUAL FUND ADVISERS TRUST
549.26K Shares
$8.135M

ARES MANAGEMENT LLC
545.723K Shares
$8.082M

LPL FINANCIAL LLC
517.416K Shares
$7.663M

BLACKROCK, INC.
483.588K Shares
$7.162M

QUBE RESEARCH & TECHNOLOGIES LTD
474.455K Shares
$7.027M

STIFEL FINANCIAL CORP
431.288K Shares
$6.387M

AMUNDI ASSET MANAGEMENT US, INC.
404.225K Shares
$5.987M

PARAMETRIC PORTFOLIO ASSOCIATES LLC
389.056K Shares
$5.762M
Summary
Only Showing The Top 20





